Pilot Study to Evaluate Serum Soluble Mesothelin-Related Peptide (SMRP) as Marker for Clinical Monitoring of Pleural Mesotheliom
Circulating biomarkers in malignant pleural mesothelioma
Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma
Frequent expression of conventional endothelial markers in pleural mesothelioma: usefulness of claudin-5 as well as combined traditional markers to distinguish mesothelioma from angiosarcoma - Lung Cancer
Diagnostic Value of CYFRA 21–1 Tumor Marker and CEA in Pleural Effusion Due to Mesothelioma - CHEST
Frontiers | The Use of Immunohistochemistry, Fluorescence in situ Hybridization, and Emerging Epigenetic Markers in the Diagnosis of Malignant Pleural Mesothelioma (MPM): A Review
Frontiers | The Use of Immunohistochemistry, Fluorescence in situ Hybridization, and Emerging Epigenetic Markers in the Diagnosis of Malignant Pleural Mesothelioma (MPM): A Review
Quantitative mass spectrometry to identify protein markers for diagnosis of malignant pleural mesothelioma - ScienceDirect
Frontiers | Liquid Biopsy in Malignant Pleural Mesothelioma: State of the Art, Pitfalls, and Perspectives
Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions - eBioMedicine
Progress in the Management of Malignant Pleural Mesothelioma in 2017 - Journal of Thoracic Oncology
Advances in Malignant Mesothelioma | NEJM
Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin
Soluble markers for diagnosis of malignant pleural mesothelioma | Biomarkers in Medicine
Frontiers | The Use of Immunohistochemistry, Fluorescence in situ Hybridization, and Emerging Epigenetic Markers in the Diagnosis of Malignant Pleural Mesothelioma (MPM): A Review
Malignant mesothelioma: A histomorphological and immunohistochemical study of 24 cases from a tertiary care hospital in Southern India Hui M, Uppin SG, Bhaskar K, Kumar NN, Paramjyothi GK - Indian J Cancer
Table 2 from Molecular profiling of malignant pleural mesothelioma and pulmonary fibrosis | Semantic Scholar
Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: evaluation in comparison with mesothelin. | Semantic Scholar
Pathology Outlines - Diffuse malignant mesothelioma
Malignant Mesothelioma Marker Selection - Mesothelioma in Focus
sensitivity (Se) and specificity (Sp) of immunohisto- chemical markers... | Download Scientific Diagram
Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis | European Respiratory Society
Guidelines for the diagnosis and treatment of malignant pleural mesothelioma - van Zandwijk - Journal of Thoracic Disease
